The meeting would have been requested by IMU, FDA approval is part of the regulatory process for approval of all new human treatments/device usage in the USA. The announcement suggests there is a clear plan for further development of the PD-1 vaccine, with no unforseen regulatory hurdles to be overcome. The time frame from initiation to final approval can take as long as 9-12 months, but is essential for human trials using the PD-1 vaccine. Successful negotiation of this process will remove a major barrier for external party risk in investment in the technology.Its definitely a step in the right direction, it suggests the management of the company have a clear understanding of the process involved, with no unexpected issues identified in the pre submission meeting.
- Forums
- ASX - By Stock
- IMU
- Ann: IMU Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx
Ann: IMU Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx, page-7
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $396.8M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.3¢ | $339.4K | 6.365M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 895592 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 672708 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9609 | 0.057 |
4 | 311818 | 0.054 |
7 | 874711 | 0.053 |
21 | 2923258 | 0.052 |
41 | 3893932 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 500 | 1 |
0.054 | 872708 | 11 |
0.055 | 1771106 | 11 |
0.056 | 1982035 | 10 |
0.057 | 1068065 | 8 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online